Drug Designing and Biomarkers

Track 8:  Drug Designing and Biomarkers

A biomarker is an attribute which will be studied as an indicator of pathogenic and biological operation alongside pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity within the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.

Drug Designing is an ingenious process to seek out new medication centered on the knowledge of biological target. Drug is most ordinarily a little molecule that inhibits or activates the function of a biomolecule, which successively outcomes during a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This sort of modelling is usually mentioned to as computer-aided drug design.

    Related Conference of Drug Designing and Biomarkers

    July 14-15, 2025

    15th World Glycobiology Congress

    Berlin, Germany
    July 17-18, 2025

    16th International Conference on Biofuels and Bioenergy

    Amsterdam, Netherlands
    September 08-09, 2025

    23rd International Conference on Structural Biology

    Frankfurt, Germany

    Drug Designing and Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in